Caribou Biosciences Inc (CRBU) average volume reaches $1.51M: Is Wall Street expecting a rally?

On Tuesday, Caribou Biosciences Inc (NASDAQ: CRBU) was -4.55% drop from the session before settling in for the closing price of $1.32. A 52-week range for CRBU has been $1.30 – $8.33.

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 71.11%. When this article was written, the company’s average yearly earnings per share was at -20.17%. With a float of $79.16 million, this company’s outstanding shares have now reached $90.55 million.

Considering the fact that the conglomerate employs 158 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 69.15%, operating margin of -1439.5%, and the pretax margin is -1289.12%.

Caribou Biosciences Inc (CRBU) Insider Activity

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Caribou Biosciences Inc stocks. The insider ownership of Caribou Biosciences Inc is 12.58%, while institutional ownership is 57.83%. The most recent insider transaction that took place on Jan 29 ’25, was worth 24,651. In this transaction Chief Financial Officer of this company bought 17,360 shares at a rate of $1.42, taking the stock ownership to the 17,360 shares.

Caribou Biosciences Inc (CRBU) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -20.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.22% during the next five years compared to -37.16% drop over the previous five years of trading.

Caribou Biosciences Inc (NASDAQ: CRBU) Trading Performance Indicators

You can see what Caribou Biosciences Inc (CRBU) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.95.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.65, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.86 in one year’s time.

Technical Analysis of Caribou Biosciences Inc (CRBU)

Compared to the last year’s volume of 1.52 million, its volume of 1.04 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 12.45%. Additionally, its Average True Range was 0.11.

During the past 100 days, Caribou Biosciences Inc’s (CRBU) raw stochastic average was set at 2.25%, which indicates a significant decrease from 11.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.18% in the past 14 days, which was lower than the 72.85% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.7053, while its 200-day Moving Average is $2.1253. Nevertheless, the first resistance level for the watch stands at $1.3267 in the near term. At $1.3933, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4467. If the price goes on to break the first support level at $1.2067, it is likely to go to the next support level at $1.1533. Should the price break the second support level, the third support level stands at $1.0867.

Caribou Biosciences Inc (NASDAQ: CRBU) Key Stats

There are 90,553K outstanding shares of the company, which has a market capitalization of 114.10 million. As of now, sales total 34,480 K while income totals -102,070 K. Its latest quarter income was 2,020 K while its last quarter net income were -34,680 K.